The Surprising Truth About Mpox Immunity: A Natural Infection May Outperform Vaccines
In a groundbreaking revelation, researchers have discovered that contracting the mpox virus (MPXV) provides a more robust and long-lasting immunity compared to vaccine-induced protection. This news, published in The Lancet Infectious Diseases on November 7, 2025, challenges our conventional understanding of vaccine efficacy.
But here's where it gets controversial... While vaccines offer a crucial defense, the study suggests that natural infection with MPXV might be a more effective strategy for long-term protection against reinfection. The researchers emphasize that vaccine-induced immunity can weaken over time, requiring booster shots to maintain its effectiveness.
The study's authors propose further investigations to determine if booster doses can enhance the durability of immunological memory in previously vaccinated individuals. If booster vaccinations prove beneficial, targeted revaccination campaigns will be essential to maintain population-level protection.
In a related commentary, researchers from the Icahn School of Medicine at Mount Sinai highlighted the importance of antigen selection in developing next-generation vaccines against orthopoxviruses, including mpox. They suggested that focusing immune responses on specific proteins associated with long-lasting protection and cross-reactivity against multiple orthopoxviruses could be the key to successful vaccine development.
Currently, the U.S. FDA-approved JYNNEOS (MVA-BN) mpox/smallpox vaccine is available at clinics and pharmacies across the United States. However, the study's findings raise important questions about the optimal approach to mpox prevention and control.
And this is the part most people miss... While vaccines are a vital tool in public health, this study underscores the complexity of the human immune system and the need for ongoing research to fully understand and harness its potential. It also highlights the importance of considering natural immunity in our strategies to combat infectious diseases.
So, what do you think? Is natural infection a better defense against mpox than vaccination? Share your thoughts and let's spark a conversation about this intriguing development in the world of immunology and infectious diseases.
